Fem Dophilus By Jarrow Formulas Overview & Drug Interactions

Check For Interactions With Fem Dophilus

Supplement: Fem Dophilus by Jarrow Formulas

Fem Dophilus Label Images

supplement image

View and download

full size label image

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Fem Dophilus by Jarrow Formulas

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Fem Dophilus. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.

Still looking for more information about Fem Dophilus interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 30
UPC/BARCODE 790011030058

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Proprietary Probiotic Blend
155 mg
Proprietary Blend --
Lacticaseibacillus rhamnosus GR-1
0 NP
TBD
Limosilactobacillus reuteri RC-14
0 NP
TBD

Other Ingredients:
Microcrystalline Cellulose
Hypromellose
Magnesium Stearate
Silicon Dioxide


Label Statments:


Formula
- Strains Matter: GR-1/RC-14 and Vaginal Flora
- Clinically Effective Probiotic Strains Over 30 years of clinical research supports the effectiveness of the 2 patented probiotic bacterial strains in Fem-Dophilus. These beneficial strains populate the vaginal tract with healthy bacteria to balance the vaginal microbiome and help maintain a healthy vaginal and urinary tract. These two strains are the most clinically published strains for vaginal health worldwide, and were carefully selected due to their effectiveness in these studies. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid, enhances probiotic bacterial survival to the lower intestine, and into the vaginal tract. Additionally, the package contains a smaller, Activ-Vial moisture-controlled desiccant bottle for better stability of probiotic bacteria. As of 8/1/2022
- 5 billion CFU 2 Clinically effective strains Maintains and balances vaginal microbriome and urinary tract health with GR-1 & RC-14 strains
General Statements
- In one randomized clinical trial, 82% of women studied had healthy vaginal flora after 28 days of use at 1.6 billion CFU per day of a probiotic (formulated with L. rhamnosus, GR-1 and L. reuteri, RC-14) compared to 50% before supplementation. Whereas in the control group (taking 10 billion CFU of common strain, L. rhamnosus GG) there was no improvement in the percentage of women with healthy vaginal flora. Reid et al. (2001). FEMS Immunol. Med. Microbiol. GR-1 and RC-14 are trademarks of Chr. Hansen A/S.
- 30+ years of clinical research
- Probiotics
Seals/Symbols
- IPRO Non GMO Project Verified Nongmoproject.org
Suggested/Recommended/Usage/Directions
- Suggested Use: Adults take 1 capsule once a day. May be taken with or without food. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
Precautions
- Warning: Consult a healthcare professional before using this product if you are pregnant, nursing, under the age of 18, are taking medication or have a medical condition; if adverse reactions occur, discontinue use.
- Warning: Consult a healthcare professional before using this product if you are pregnant, nursing, under the age of 18, are taking medication or have a medical condition; if adverse reactions occur, discontinue use.
- Keep out of the reach of children.
- Do not use if safety seal is damaged or missing.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Brand IP Statement(s)
- Over 30 years of clinical research supports the effectiveness of the 2 patented probiotic bacterial strains in Fem-Dophilus. Copyright 2023 Jarrow Formulas
- Reid et al. (2001). FEMS Immunol. Med. Microbiol. GR-1 and RC-14 are trademarks of Chr. Hansen A/S.
Formulation
- Vegan
- Vaginal & urinary tract
- Non-GMO Gluten free
- No wheat, gluten, soybeans, dairy, egg, fish/shellfish, peanuts/tree nuts or sesame.
- Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.
Storage
- Keep refrigerated
- Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.
FDA Statement of Identity
- Probiotic Supplement

Brand Information

See all products by this brand

Distributed by
Name Jarrow Formulas, Inc.
City Sherman Oaks
State CA
Country USA
ZipCode 91403
Phone Number 1-866-459-4154
Web Address www.Jarrow.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.